Qube Research & Technologies (QRT)
AIM

Qube Research & Technologies (QRT)’s AIM ImmunoTech AIM Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Hold
0
– – – 4400
2024
Q2 		– Hold
0
– – – 4981
2024
Q1 		– Hold
0
– – – 4400
2023
Q4 		– Hold
0
– – – 4292
2023
Q3 		– Hold
0
– – – 4056
2021
Q4 		– Sell
-158
Closed -$32K – 3224
2021
Q3 		$32K Buy
+158
New +$31.9K ﹤0.01% 1915

Other funds holding AIM

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Qube Research & Technologies (QRT)'s AIM Position: Q3 2024 in Review

Qube Research & Technologies (QRT) held its AIM ImmunoTech (AIM) position steady in Q3 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4400.

Qube Research & Technologies (QRT) first reported a position in AIM in Q3 2021 and has held it in 1 quarter since. The position peaked at $32K in Q3 2021. 30 funds tracked by Wall St. Rank hold AIM as of Q3 2024.

  • Qube Research & Technologies (QRT) held 0 shares of AIM ImmunoTech worth $0 as of Q3 2024.
  • Qube Research & Technologies (QRT) left its AIM ImmunoTech share count unchanged in Q3 2024.
  • AIM ImmunoTech made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2024, its #4400 holding.
  • Qube Research & Technologies (QRT) first reported a position in AIM ImmunoTech in Q3 2021 and has held it in 1 quarter since.
  • Qube Research & Technologies (QRT)'s AIM ImmunoTech position peaked at $32K in Q3 2021.
  • 30 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.